7-BROMO-2,4-DICHLOROPYRIDO[3,2-D]PYRIMIDINE, 95%, 250mg

1-[[2'-(2,5-Dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]methyl]-2-ethoxy-1H-benzimidazole-7-carboxylic acid methyl ester, 98%, 100g

2-Methylthiazole-4-carbonitrile, 95.0%, 5g

4-Chloro-7-methoxyquinazolin-6-yl acetate, 95.0%, 10g

2-Bromo-3-(chloromethyl)pyridine, 95.0%, 1g

N-methyl-1-(1-methyl-1H-imidazol-2-yl)methanamine dihydrochloride, 95.0%, 1g

3-(4-Bromophenyl)propan-1-ol, 95.0%, 10g

O-(Propargyl)-N-(triethoxysilylpropyl)carbamate (inhibited with MEHQ), 90%, 1g

1,5-dimethyl-1H-pyrrole-2-carboxylic acid, 95.0%, 250mg

2-(2-Chloro-acetylamino)-6-methyl-4,5,6,7-tetrahydro-benzo[b]thiophene-3-carboxylic acid ethyl ester, 95.0%, 1g

4-Chlorostyrene (stabilised with TBC), 99.00%, 25g

5-chloro-7-iodo-2H-pyrazolo[3,4-c]pyridine, 98%, 250mg

Methyl 2,4-difluoro-3-nitrobenzoate, 98%, 500mg